Therapeutic plaster for trigger and acupuncture points, as well as for meridian therapy

FIELD: medicine.

SUBSTANCE: invention refers to medicine. What is described is a therapeutic plaster for local application of natural drugs applicable for oral administration and/or for injection, containing the following components: - a pillow made of a bearing material, at least for one natural drug either fluid, or introduced in a solution, a coating completely covering the pillow and projecting at least from two sides with a skin-adhesive layer, and at least one natural drug either fluid, or introduced in a solution either in the bearing material, or in a reservoir opening to the bearing material, and is used for stimulating or treating, particularly, in trigger and acupuncture points, as well as for meridian therapy.

EFFECT: substances inactive or low-effective percutaneously if applied in certain skin regions, particularly for a long period of time, can exhibit previously unused action ensured by slow release from the bearing material.

10 cl, 4 dwg

 

The invention relates to therapeutic patch for local use of natural therapeutic drugs, also called natural medicines, and generally to the use of liquid or introduced into a solution of natural medicines, which are suitable for oral administration or for injection within a carrier material and, in particular, in the form of a therapeutic patch on the skin to stimulate and treatment, in particular, trigger and acupuncture points and Meridian therapy.

The invention is based on the fact that substances through the skin by themselves do not work or are not effective, when used in certain places of the skin and, in particular, for a long time, may be due to the gradual allocation of the media is not used to date the action.

Therefore, the objective of the invention is to allow the use of well-known natural medicinal products, in particular, is known homeopathic medicines, to other alternative treatments.

To solve this problem provides a therapeutic patch for local use of natural medicines, which has the following components:

- the bed of carrier material, at least one is Idaho or introduced into a solution of natural medicines,

- fully covering the pillow and acting at least on two sides coated with adhesive to the skin layer and

at least one liquid or introduced into a solution of natural medicine in the raw material or the opening to the supporting material in the tank.

Preferably liquid or introduced into the solution natural medicine is a homeopathic remedy. It is usually, if in liquid form, in a physiological salt solution, and can be used in therapeutic patch in this form. External action, respectively, the application of the remedies is usually unknown.

The effect is caused by the fact that the properties of the skin and underlying tissues at specific neurological trigger points, acupuncture points and along certain meridians are special (in particular, different is the anatomy of the skin, such as skin resistance less) and thus may be more sensitive to the use of the substance and information.

As found by the applicant on the basis of their many years of practical experience, natural medicines and homeopathic remedies, when they are applied, for example, in the liquid on the swab and superimposed on one of these selected points of the skin, in an unexpected way are known Proc. of the traditional natural healing without side effects such as redness of the skin.

The invention allows a simple way to reveal additional therapeutic possibilities of application of the known liquid medicine that is usually known only to oral therapy or injections. This can be used, for example, in hospitals or directly from the physician via topical use of available liquid funds via open here therapeutic patch. This patch (in the form of "empty" patch) can be filled with the manufacturer or, if necessary, in the hospital or at the pharmacy. Fully trained filled patch also simplifies and speeds up the handling of medical personnel.

In the private sector, and the use without supervision by a doctor is the patch must ensure the reliability, simplicity, and security. This is also ensured by the patch according to the invention, as will be more fully explained below. Due to this, it is possible to reduce the number of visits to the doctor.

Therapeutic possibilities of application of a variety. The patches may be applied to the skin alone (i.e. without other medical measures), it is possible to simultaneously use multiple patches at different points during the other treatment, such as acupuncture at other points. The patches may also preferably nano is arranged in places of acupuncture perforations or in places perforation for injection. Naturally, this patch must meet the conditions of sterility.

Therefore, the invention also covers a set of therapeutic patch above, and filled pre-filled syringe, as well as alternative solutions of therapeutic patches and capsules to fill the syringe. Especially preferred in the present time is soothing the pain of a set of ampoules with a homeopathic remedy or natural treatment with indication of psychosomatic illnesses and/or conditions of physical exhaustion, preferably Neuroinjeel®, or filled pre-filled syringe with this tool and the patch containing Valeriana officinalis means, preferably Valerianaheel®, the following media and fluids.

Similarly, you can combine other means prescribed by the doctor depending on the application.

Additionally, the invention encompasses a kit for a therapeutic patch specified in detail above. Set contains, on the one hand, a blank patch ("empty" patch, as mentioned above), which does not contain in its raw material or in the reservoir of natural medicine, and advanced liquid or introduced into a solution of natural medicine, which is provided for filling not the current material of plaster or reservoir patch, in a closed vessel. The vessel may be, for example, a vial or bottle, for example dropper. From this set, the patient, physician, or pharmacist can produce therapeutic plaster according to the invention in place by filling the carrier material or provided for the tank.

Embodiments of patch

For receiving the active substance, i.e. the liquid preparation normally provide "supporting material". Specialists are known from the literature numerous supporting materials for surface applications, which are usually also denoted by the term. Preferably the carrier material is a sponge, natural origin, the foam material (of various plastics), i.e. a pillow made of foam, gel (e.g., silicone or polyurethane, preferably a hydrogel), absorbent non-woven material, gauze (cotton gauze), absorbent cellulose material, or material with inorganic constituents, which may also be made, for example, in the shell, such as a thin permeable film or filter paper. These inorganic materials can be, for example, zeolites, layered minerals, clays and the like, or these materials can be embedded in other materials, such as, for example, foam, Il the gel.

The active substance must be obtained in the liquid, respectively, fluid environment in order to ensure the possibility of migration or diffusion of the active substance, respectively, extending through the liquid structure. The dry preparation can not penetrate from the dry media in the direction of the target zone. However, you can mix the product with fat or oil. That is, liquid or flowable form tools should not be water or only water. Instead of the solution of natural medicines can also be used emulsion (water in oil or oil in water), the tool in this case, dissolved, at least one of the phases. Therefore, the fluid phase can be also ointment, cream, paste, gel or solution.

Particularly preferably, when the solution natural remedies is nanosome or microsomes within a fluid phase or emulsion, because the onset of action and duration of action may very well be controlled using nanosonic and microsome technologies.

Stabilized by physical surface nanosomes and microsome assay give their content only slowly due to the heat of the body in contact with skin. It is already known from applications of creams.

As natural medicines, in particular homeopathy, you can use the well-known W is dcie applications, which are usually sealed in standard form (with a standard concentration of the drug) or in the form of drops in the bottle/dropper. These tools are usually designed on the basis of physiological NaCl solution, so can not cause irritation of the skin, or they contain a fraction of alcohol, which, however, does not exceed the allowable for the skin limits (for example, French vodka for circulation).

Moreover, preferably provided that the patch has a reservoir for natural medicines, which, when in use must be open. This tank is desirable when you want a longer preservation of the patch to prevent drying of the impregnated carrier or some reaction between the active substance and a carrier, which may occur during storage. The tank is also particularly preferred, when to expect adverse storage conditions or hot climate. This ensures the achievement of the emitted dose over time. Therefore, it may be preferable to enclose the liquid in the capsule, respectively, a small vessel and release him only shortly before use. For this purpose, the tank can have, in particular, place a given fracture. Of course, a valid alternative possibilities, such as the tank once Ivate or pierced with a thorn.

In a particularly preferred embodiment, the cushion-side applications can be covered with a semi-permeable membrane, namely so that the tool can diffuse through the membrane on the side of the skin, however, reliably prevents reverse flow to the skin surface of the bearing material.

In one particularly preferred embodiment, the entire patch is covered by the use of a removable film or remove the paper.

For the layer of adhesive, with which the patch should be kept on the patient's skin, especially suitable contact adhesives which are known from conventional plasters for application to wounds.

The coating may be composed of any suitable material, for example textile material or film. This is also known very usable materials from the usual patches of a different kind, which do not require special description.

As mentioned above, the invention covers broadly the use of liquid or introduced into a solution of natural medicines, preferably homeopathic remedies, which are suitable for oral administration or for injection (intravenously or under the skin), within a carrier material and, in particular, as explained in detail above therapeutic patch on the skin to stimulate or treatment, in particular, to trigger the acupuncture points, and Meridian therapy.

Therapeutic use

Possible applications are very diverse and open a completely new field whose value is not yet fully appreciate.

Some examples

- Support for small surgical procedures, also in dental surgeries, gastroenterology, urology and so on

Manufacturer of homeopathic pain relievers sets (sets for training operations), for example:

1 ampoule Neuroinjeel in the form of pre-filled syringe is mounted on the trigger point and

1 patch with ValerianaheelTMsuperimposed on the injection site; shape and number are variable depending on the growth of the patient. Therapy is also possible for children and animals. Analgesic effect lasts in this example, for about 1.5 hours, which is sufficient for small interventions.

- Nerve regeneration after apoplexy or injury to the nerves.

The patch with regenerating nerves medication impose on the trigger or acupuncture points.

Treatment of stomach, intestines, depletion via trigger or acupuncture points.

- Reduction of spasticity on the relevant trigger or acupuncture points.

Neuroinjeel® is the tool for applications: psychosomatic painful condition, physical exhaustion, and the soda is separated by the following ingredients:

Acidum phosphoricum D 10, Acidum phosphoricum D 30, Argentum nitricum D 10, Argentum nitricum 30 D, Platinum metallicum D 10, Platinum metallicum 30 D, Sepia D 10, Sepia 30 D, Valeriana D 10, Valeriana D 30, Anhalonium lewinii 30 D in the amount of 1.1 µl of each 1.1 ml of total solution and Avena sativa D 10, D Avena sativa 30, Ignatia D 10, Ignatia 30 D in the amount of 2.2 μl each 1.1 ml of total solution.

Valerianaheel® is a medium with the following composition:

Valeriana officinalis 2x, Picricum acidum 6x, Prunus spinosa 2x, Humulus lupulus 2x, Hypericum perforatum 3x, Melissa officinalis 2x, Avena sativa 2x, Chamomilla 2x, Ammonium Bromatum 2x, Kali bromatum 2x, Natrium bromatum 2x.

Other means can be combined in a similar manner chosen by the doctor depending on the application.

Below is a detailed explanation of the invention in the examples with reference to the accompanying drawings, which depict:

figure 1 is an example cross-sectional view of the first run of therapeutic patch with a simple design;

figure 2 is another cross-sectional view of performing a therapeutic patch;

figure 3 - the patch according to figures 1 and 2 when viewed from above;

4 is a cross section of another exemplary embodiment of therapeutic patch with the tank, a-e: the various stages of application.

Figure 1 shows the first exemplary embodiment of the patch indicated by item 10, consisting of a cushion 1 of the supporting material, in this case, the foam sponge, under the cover 2 with the adhesive layer 3 for mounting the patch on to the e of the patient. The coating 2 is made so that the airbag 1 is closed completely. In this example implementation, there is no reservoir, so that the foam sponge directly impregnated with liquid or introduced into the solution as a natural treatment. Foam sponge 1 is covered on the side of the skin of a semi-permeable membrane 4. Then the whole patch (above adhesive layer 3 and a semi-permeable membrane 4) is covered with a removable film, which in this simplified view is not shown. Continuous shooting paper can be located many patches.

Figure 2 shows a modified exemplary embodiment, which has the additional compensation pillow around 5 carrier bags 1. Thus, thick cushion 1 is better protected from lateral shear.

On figa and b are shown in the top view two possible options for the patch according to figures 1 and 2, namely, one round and one rectangular. Of course, other possible forms.

Figure 4 shows a more divided into compartments patch 10 with additional tank 6, which may be made of plastic. On figa tank 6 shows empty. The tank 6 has side walls 6A, which are in the direction of the carrier over a bowl-shaped protrusion 7. The side walls 6A is connected with the cover 2, or can be easily separated from it. On fig.4b shows a tank filled with the being. On figs designated as side walls 6A of the tank 6 can be pressed down at this location given the destruction of the edge membrane 7 dissolved, and the liquid from the reservoir is emptied into the base cushion 1. On fig.4d shown again in more detail, the side walls 6A here is almost fully open. On file shown that the patch is in the final state is almost completely flat on its upper side, because the entire contents of the tank 6 devastated in the carrier 1. Closing 6 capsules for medication as follows: under prepared for perforation location on the underside of the capsule is with the size of a pea Cup-shaped closing cover 7. After removal of the drug, when the desolate capsule (tank 6) carries out the suction capsule for the expense incurred vacuum sucks closing the lid 7. Additionally, to ensure getting the entire dose of medication in place of steps provided that the lower part of the capsule is sealed with a closing film 6b of the upper branch. Thus preventing erection again the capsules and thereby the suction back of the medication.

1. therapeutic patch for local use natural medicines containing the bed of carrier material, at least one liquid or made in rest the R natural medicines coating with adhesive to the skin layer fully covering the pillow and acting at least on two sides and at least one liquid or introduced into a solution of natural medicine in the raw material or the opening to the bearing material reservoir, wherein the liquid or introduced into the solution natural medicine is a homeopathic remedy and pillow from the use of covered palanimanickam membrane.

2. therapeutic patch according to claim 1, characterized in that the carrier material is a sponge, a foam material, a gel, absorbent non-woven material, gauze, absorbent cellulose material, or material with inorganic components.

3. therapeutic patch according to claim 1, wherein the patch has a reservoir for natural medicines, which is subject to mechanical opening when in use.

4. therapeutic patch according to claim 3, characterized in that the reservoir is specified destruction for destruction immediately before use and release of drug in the carrier material.

5. therapeutic patch according to claim 1, characterized in that the entire patch from the application covered with a removable film or remove the paper.

6. The use of liquid or vneseno what about the solution of the natural medicines inside the supporting material in the form of a therapeutic patch according to any one of claims 1 to 5 for application to the skin to stimulate and treatment, in particular, trigger and acupuncture points and Meridian therapy, characterized in that the natural remedy is a homeopathic remedy.

7. Set for a therapeutic patch according to any one of claims 1 to 5, characterized in that the kit contains a blank patch, which in its raw material or in the tank does not contain natural drug, and optionally a liquid or introduced into a solution of natural medicine in a closed container.

8. Set of therapeutic patch according to any one of claims 1 to 5 and filled pre-filled syringe or, as an alternative solution, ampoule filling syringe.

9. The kit according to claim 7, characterized in that it is set with HUD therapy pain and vial or completed the pre-filled syringe contains homeopathic remedy or natural remedy with indication of psychosomatic medical conditions and/or physical exhaustion.

10. The set of claim 8, wherein the patch contains contains Valeriana officinalis tool.



 

Same patents:

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine and chemical-pharmaceutical industry, particularly creating an oral film drug which when taken adheres to an oral mucosa, and even if adheres is easily detached therefrom. The oral film drug has at least one agent-containing layer, and at least one surface of the oral drug has a convex portion. Said convex portion is presented in the form of at least one forms specified in cones, columns, hemispheres, truncated cones. The agent-containing layer consists of a therapeutic agent and a base.

EFFECT: preparing the oral film agent.

10 cl, 4 ex, 1 tbl, 9 dwg

FIELD: chemistry.

SUBSTANCE: invention relates to a collagenic film and a method of making said film. The film contains at least one collagenic layer. The surface of the collagenic layer is formed by a plurality of domains with predominant orientation of collagenic fibres in each domain and continuous variation of orientation of fibres from one domain to another. There are pores on the domain boundary.

EFFECT: possibility of stable formation of structures similar to natural collagen.

22 cl, 21 dwg, 13 tbl

FIELD: medicine.

SUBSTANCE: invention refers to medicine. What is described is a therapeutic system for introduction of a pharmaceutically active substance, nonvolatile at least at room temperature, with a daily dose max. 30 mg, comprising a skin non-contact and active substance impenetrable external layer, an adjacent skin distant polymeric layer of polyisobutylene of the coating weight at least 80 g/m2, an adjoining skin contact adhesive polymeric layer of acrylate copolymers of the coating weight max. 50 g/m2, and also an active substance impenetrable protective layer (easily) removed from the skin contact layer.

EFFECT: transdermal therapeutic system has a high level of using the active ingredient and a higher dose accuracy.

18 cl, 2 ex

FIELD: medicine.

SUBSTANCE: present invention refers to medicine, more specifically to a gel composition for a medical material or a hygienic material which contains a liquid rubber ingredient having a functional group able to create cross linkages, in a molecule, and 90 weight parts or more and 1250 weight parts or less of an organic liquid ingredient in relation to 100 weight parts of the rubber ingredient with the gel composition being cross-linked.

EFFECT: composition for the medical material or the hygienic material contains a great amount of the organic liquid ingredient, has sufficient elasticity and can hold its shape.

7 cl, 4 tbl

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine. What is described is an adhesive composition containing donepezil and a stabiliser. The stabiliser containing one or more compounds specified in a group consisting of ascorbic acid, metal salt or ester of such, isoascorbic acid or metal salt of such, ethylene-diamine-tetraacetic acid or metal salt of such, cysteine, acetylcysteine, 2-mercaptobenzimidazole, 3(2)-tert-butyl-4-hydroxyanisol, 2,6-di-tert-butyl-4-methylphenol, tetrakis[3-(3',5'-di-tert-butyl-4'-hydroxyphenyl)]propionate pentaerythrite, 3-mercapto-1,2-propanediol, tocopherol acetate, rutin, quercetin, hydroquinone, metal salt of hydroxymethansulphinic acid, metabisulphite metal salts, sulphite metal salt and thiosulphate metal salts; it is added to a layer of a pressure sensitive adhesive applied on at least one side of the substrate.

EFFECT: prepared high reliable and stable adhesive composition which inhibits formation of donepezil-related compounds in the layer of the pressure sensitive adhesive.

14 cl, 4 tbl

FIELD: medicine.

SUBSTANCE: invention refers to medicine. There are described Transdermal Therapeutic Systems having a silicone adhesive layer, and a method for producing and using them.

EFFECT: transdermal therapeutic systems provide achieving a certain plasma concentration.

23 cl, 3 tbl, 4 dwg, 1 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine. What is disclosed is a dosage form containing a base and a self-adhesive layer which contains a medicinal agent and covers at least one of the base sides; wherein the base consists of a polyester film of the thickness of 0.5 to 6.0 mcm, and a polyester non-woven material directly coupled with the film. The base is coated with the self-adhesive layer either directly or through an intermediate layer from the non-woven material.

EFFECT: adhesive preparation have sufficient elasticity for the purpose of tracking of the skin shape, as well as shows low ability to irritate the skin and high stability.

7 cl, 5 tbl, 7 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine. What is described is a film containing as a film-forming agent an alginic acid salt with monovalent cation or mixed alginic acid salts containing at least one alginic acid salt with monovalent cation with 10% aqueous solution of the film-forming agent at temperature 20°C characterised by the viscosity of 100-1000 mPa-sec in accordance with the values measured at shear velocity 20 rpm with using a Brookfield viscometre equipped with a spindle No.2, as well as a method for making such film.

EFFECT: film is applicable for active ingredient delivery in a mammal's body and fast soluble while contacting with a wet surface.

18 cl, 2 tbl, 10 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine, namely an adhesive preparation for percutaneous introduction of 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocyclooctate[b]pyridine (compound A). The preparation contains an adhesive layer formed on one base surface wherein the adhesive layer contains (1) the compound A or its physiologically acceptable salt formed by salt addition, and (2) an acryl adhesive, or (1) the compound A or its physiologically acceptable salt formed by salt addition, (2) the acryl adhesive and (3) a permeability enhancing agent.

EFFECT: preparation inhibits metabolite generation and continuously maintains the blood drug concentration.

19 cl, 7 tbl, 1 dwg, 63 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine. What is described is an adhesive composition which decreases a number of donepezil related compounds formed in the donepezil-containing adhesive composition containing one, two or more types of combinations of the compounds selected from the following groups of the combinations of the compounds from (a) to (j) which are mixed in a layer of a donepezil-containing pressure sensitive glue: (a) isoascorbic acid or its metal salts and 2-mercaptobenzimidazole; (b) isoascorbic acid or its metal salts and 2,6-di-tert-butyl-4-methylphenol; (c) isoascorbic acid or its metal salts and metal salts of hydroxymethane sulphinic acid; (a) isoascorbic acid or its metal salts and rutin; (e) 2-mercaptobenzimidazole and 2,6-di-tert-butyl-4-methylphenol; (f) 2-mercaptobenzimidazole and metal salts of of hydroxymethane sulphinic acid; (g) 2-mercaptobenzimidazole and rutin; (h) 2,6-di-tert-butyl-4-methylphenol and metal salts of hydroxymethane sulphinic acid; (i) 2,6-di-tert-butyl-4-methylphenol and rutin; and (j) metal salts of hydroxymethane sulphinic acid and rutin.

EFFECT: adhesive composition is highly reliable and stable.

12 cl, 2 tbl

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to cosmetics and concerns a composition containing 50 wt % or less of a Vaseline-like compound representing an unsaturated polyol ester prepared by an exchange reaction and/or a partially or completely hydrated unsaturated polyol ester prepared by an exchange reaction specified in a group consisting of vegetable oil, algae oil or animal fat, and having an iodine value 120 or less, a pour point 37.8°C to 60.0°°C, conic penetration at 25°C 100 dmm to 300 dmm, a drop melting point 37.8°C to 65.6°C, viscosity at 210° F approximately 100 SUS or less. The invention also discloses an emulsion with its dispersion form representing said unsaturated polyol ester prepared by an exchange reaction and/or partially or completely hydrated unsaturated polyol ester prepared by an exchange reaction, as well as a personal hygiene product containing said emulsion.

EFFECT: invention provides the Vaseline-like compositions which may be used as oil-based Vaseline substitutes.

26 cl, 6 dwg, 9 tbl, 6 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to cosmetics and concerns a composition containing 50 wt % or less of a Vaseline-like compound representing an unsaturated polyol ester prepared by an exchange reaction and/or a partially or completely hydrated unsaturated polyol ester prepared by an exchange reaction specified in a group consisting of vegetable oil, algae oil or animal fat, and having an iodine value 120 or less, a pour point 37.8°C to 60.0°°C, conic penetration at 25°C 100 dmm to 300 dmm, a drop melting point 37.8°C to 65.6°C, viscosity at 210° F approximately 100 SUS or less. The invention also discloses an emulsion with its dispersion form representing said unsaturated polyol ester prepared by an exchange reaction and/or partially or completely hydrated unsaturated polyol ester prepared by an exchange reaction, as well as a personal hygiene product containing said emulsion.

EFFECT: invention provides the Vaseline-like compositions which may be used as oil-based Vaseline substitutes.

26 cl, 6 dwg, 9 tbl, 6 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents an oil-in-water emulsion composition containing: (A) polyoxyethylene phytosterine, (B) diester of glycerol and fatty acid; (C) a static copolymer of polyoxyethylene-polyoxypropylene dialkyl ester, (D) a fat-soluble medicine; and (E) oil and (F) water wherein an emulsion particle of the emulsion composition contains a layer gel structure consisting of the ingredients (A) and (B).

EFFECT: invention provides creating the oil-in-water emulsion composition which stably contains a fat-soluble medicine and makes a favourable sensations when used.

10 cl, 8 ex, 8 dwg

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents an oil-in-water emulsion composition containing: (A) polyoxyethylene phytosterine, (B) diester of glycerol and fatty acid; (C) a static copolymer of polyoxyethylene-polyoxypropylene dialkyl ester, (D) a fat-soluble medicine; and (E) oil and (F) water wherein an emulsion particle of the emulsion composition contains a layer gel structure consisting of the ingredients (A) and (B).

EFFECT: invention provides creating the oil-in-water emulsion composition which stably contains a fat-soluble medicine and makes a favourable sensations when used.

10 cl, 8 ex, 8 dwg

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents an oil-in-water emulsion composition containing: (A) polyoxyethylene phytosterine, (B) diester of glycerol and fatty acid; (C) a static copolymer of polyoxyethylene-polyoxypropylene dialkyl ester, (D) a fat-soluble medicine; and (E) oil and (F) water wherein an emulsion particle of the emulsion composition contains a layer gel structure consisting of the ingredients (A) and (B).

EFFECT: invention provides creating the oil-in-water emulsion composition which stably contains a fat-soluble medicine and makes a favourable sensations when used.

10 cl, 8 ex, 8 dwg

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents an oil-in-water emulsion composition containing: (A) polyoxyethylene phytosterine, (B) diester of glycerol and fatty acid; (C) a static copolymer of polyoxyethylene-polyoxypropylene dialkyl ester, (D) a fat-soluble medicine; and (E) oil and (F) water wherein an emulsion particle of the emulsion composition contains a layer gel structure consisting of the ingredients (A) and (B).

EFFECT: invention provides creating the oil-in-water emulsion composition which stably contains a fat-soluble medicine and makes a favourable sensations when used.

10 cl, 8 ex, 8 dwg

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents an oil-in-water emulsion composition containing: (A) polyoxyethylene phytosterine, (B) diester of glycerol and fatty acid; (C) a static copolymer of polyoxyethylene-polyoxypropylene dialkyl ester, (D) a fat-soluble medicine; and (E) oil and (F) water wherein an emulsion particle of the emulsion composition contains a layer gel structure consisting of the ingredients (A) and (B).

EFFECT: invention provides creating the oil-in-water emulsion composition which stably contains a fat-soluble medicine and makes a favourable sensations when used.

10 cl, 8 ex, 8 dwg

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents an oil-in-water emulsion composition containing: (A) polyoxyethylene phytosterine, (B) diester of glycerol and fatty acid; (C) a static copolymer of polyoxyethylene-polyoxypropylene dialkyl ester, (D) a fat-soluble medicine; and (E) oil and (F) water wherein an emulsion particle of the emulsion composition contains a layer gel structure consisting of the ingredients (A) and (B).

EFFECT: invention provides creating the oil-in-water emulsion composition which stably contains a fat-soluble medicine and makes a favourable sensations when used.

10 cl, 8 ex, 8 dwg

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to cosmetology and dermatology and represents a composition for treating dermatological disorders containing in a physiologically acceptable medium, at least: (i) peroxide benzoyl, (ii) a naphthoic acid derivative specified in 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid, 6- [3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthoic acid, 6-[3-(1-adamantyl)-4-decyloxyphenyl]-2-naphthoic acid and 6-[3-(1-adamantyl)-4-hexyloxyphenyl]-2-naphthoic acid and (iii) a compound of polyurethane polymer representing a polyol pre-polymer with said naphthoic acid derivative and said benzoyl peroxide being found in the dispersed form in said composition.

EFFECT: invention provides producing a non-irritant stable composition.

25 cl, 8 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to cosmetology and dermatology and represents a composition for treating dermatological disorders containing in a physiologically acceptable medium, at least: (i) peroxide benzoyl, (ii) a naphthoic acid derivative specified in 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid, 6- [3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthoic acid, 6-[3-(1-adamantyl)-4-decyloxyphenyl]-2-naphthoic acid and 6-[3-(1-adamantyl)-4-hexyloxyphenyl]-2-naphthoic acid and (iii) a compound of polyurethane polymer representing a polyol pre-polymer with said naphthoic acid derivative and said benzoyl peroxide being found in the dispersed form in said composition.

EFFECT: invention provides producing a non-irritant stable composition.

25 cl, 8 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine. What is described is a therapeutic system for introduction of a pharmaceutically active substance, nonvolatile at least at room temperature, with a daily dose max. 30 mg, comprising a skin non-contact and active substance impenetrable external layer, an adjacent skin distant polymeric layer of polyisobutylene of the coating weight at least 80 g/m2, an adjoining skin contact adhesive polymeric layer of acrylate copolymers of the coating weight max. 50 g/m2, and also an active substance impenetrable protective layer (easily) removed from the skin contact layer.

EFFECT: transdermal therapeutic system has a high level of using the active ingredient and a higher dose accuracy.

18 cl, 2 ex

Up!